
Kazuo Ueda
16:08 JST, February 11, 2023
TOKYO (Jiji Press) — The dollar plummeted below ¥130.50 in Tokyo trading Friday, hit by selling triggered by a media report on the next Bank of Japan governor.
At 5 p.m., the dollar stood at ¥130.44-44, down from ¥131.14-15 at the same time Thursday. The euro was at $1.0741-0741, up from $1.0734-0734, and at ¥140.11-12, down from ¥140.76-77.
The dollar rose close to ¥131.90 in midmorning trading, aided by buying by Japanese importers and rising U.S. long-term interest rates in premarket trading.
After moving in the upper 131-yen range amid a lack of fresh news, the U.S. currency quickly lost ground in late afternoon trading in the wake of a media report that former BOJ Policy Board member Kazuo Ueda will replace Haruhiko Kuroda, whose tenure as head of the central bank will end in April.
“Investors reacted to the news by tentatively selling the dollar against the yen” after buying the greenback on a report earlier this week that dovish BOJ Deputy Gov. Masayoshi Amamiya had been asked to succeed Kuroda, an official at a foreign exchange margin trading service firm said.
The Amamiya nomination news had raised the view that the BOJ would keep implementing ultraeasy policy. “But we don’t know about who Ueda actually is or his policy stance,” a Japanese securities firm official said.
Top Articles in News Services
-
Survey Shows False Election Info Perceived as True
-
Japan’s Nikkei Stock Average Falls as US-Iran Tensions Unsettle Investors (UPDATE 1)
-
Japan’s Nikkei Stock Average Rises on Tech Rally and Takaichi’s Spending Hopes (UPDATE 1)
-
Japan to Ban Use of Power Banks on Airplanes
-
North Korea Unveils Image of Kim Jong Un’s Teenage Daughter Firing Rifle
JN ACCESS RANKING
-
Producer Behind Pop Group XG Arrested for Cocaine Possession
-
Japan PM Takaichi’s Cabinet Resigns en Masse
-
Man Infected with Measles Reportedly Dined at Restaurant in Tokyo Station
-
Japan Figure Skating Legend Yuzuru Hanyu Is Proud Disaster Survivor and Gold Medalist, Vows to Continue Support Efforts
-
iPS Treatments Pass Key Milestone, but Broader Applications Far from Guaranteed

